M Terzolo

Summary

Publications

  1. ncbi Adjuvant mitotane treatment for adrenocortical carcinoma
    Massimo Terzolo
    Universita di Torino, Turin, Italy
    N Engl J Med 356:2372-80. 2007
  2. ncbi Adrenal incidentaloma: a new cause of the metabolic syndrome?
    Massimo Terzolo
    Dipartimento di Scienze Cliniche e Biologiche, Medicina Interna I, Clinica Medica, A S O San Luigi, 10043 Orbassano, Italy
    J Clin Endocrinol Metab 87:998-1003. 2002
  3. ncbi Acute administration of melatonin at two opposite circadian stages does not change responses to gonadotropin releasing hormone, thyrotropin releasing hormone and ACTH in healthy adult males
    P Paccotti
    Dipartimento di Biomedicina, Ospedale S Vito, Torino, Italy
    J Endocrinol Invest 10:471-7. 1987
  4. ncbi Clinicopathological study of a series of 92 adrenocortical carcinomas: from a proposal of simplified diagnostic algorithm to prognostic stratification
    Marco Volante
    Division of Pathology, Department of Clinical and Biological Sciences, University of Turin at San Luigi Hospital, Turin, Italy
    Histopathology 55:535-43. 2009
  5. ncbi Emerging drugs for adrenocortical carcinoma
    Alfredo Berruti
    Department of Clinical and Biological Science, Oncologia Medica, University of Turin, Azienda Ospedaliera San Luigi, Regione Gonzole 10, 10043 Orbassano, Italy
    Expert Opin Emerg Drugs 13:497-509. 2008
  6. ncbi Hyperhomocysteinemia in patients with Cushing's syndrome
    Massimo Terzolo
    Dipartimento di Scienze Cliniche e Biologiche, Medicina Interna I, Universita di Torino, 10100 Torino, Italy
    J Clin Endocrinol Metab 89:3745-51. 2004
  7. ncbi The neoplastic complications of acromegaly
    M Terzolo
    Department of Clinical and Biological Sciences, Internal Medicine I, A.S.O. San Luigi, University of Turin, Orbassano, Turin, Italy
    J Endocrinol Invest 26:32-4. 2003
  8. ncbi Colonoscopic screening and follow-up in patients with acromegaly: a multicenter study in Italy
    Massimo Terzolo
    Dipartimento de Scienze Cliniche e Biologische, Clinica Medica, Universita di Torino, Italy
    J Clin Endocrinol Metab 90:84-90. 2005
  9. ncbi Subclinical Cushing's syndrome in adrenal incidentalomas
    Massimo Terzolo
    Division of Internal Medicine, University of Turin, Azienda Sanitaria Ospedaliera San Luigi, Regione Gonzole 10, 10043 Orbassano, Italy
    Endocrinol Metab Clin North Am 34:423-39, x. 2005
  10. ncbi Midnight serum cortisol as a marker of increased cardiovascular risk in patients with a clinically inapparent adrenal adenoma
    Massimo Terzolo
    Dipartimento di Scienze Cliniche e Biologiche, Medicina Interna I, Universita di Torino, Turin, Orbassano, Italy
    Eur J Endocrinol 153:307-15. 2005

Detail Information

Publications60

  1. ncbi Adjuvant mitotane treatment for adrenocortical carcinoma
    Massimo Terzolo
    Universita di Torino, Turin, Italy
    N Engl J Med 356:2372-80. 2007
    ..Whether the use of mitotane is beneficial as an adjuvant treatment has been controversial. Our aim was to evaluate the efficacy of adjuvant mitotane in prolonging recurrence-free survival...
  2. ncbi Adrenal incidentaloma: a new cause of the metabolic syndrome?
    Massimo Terzolo
    Dipartimento di Scienze Cliniche e Biologiche, Medicina Interna I, Clinica Medica, A S O San Luigi, 10043 Orbassano, Italy
    J Clin Endocrinol Metab 87:998-1003. 2002
    ..Midnight serum cortisol appears as a sensitive marker of the metabolic effects of subclinical Cushing's syndrome...
  3. ncbi Acute administration of melatonin at two opposite circadian stages does not change responses to gonadotropin releasing hormone, thyrotropin releasing hormone and ACTH in healthy adult males
    P Paccotti
    Dipartimento di Biomedicina, Ospedale S Vito, Torino, Italy
    J Endocrinol Invest 10:471-7. 1987
    ..The circadian chronosusceptibility of pituitary and adrenocortical cells to specific stimuli deserves interest to future investigation...
  4. ncbi Clinicopathological study of a series of 92 adrenocortical carcinomas: from a proposal of simplified diagnostic algorithm to prognostic stratification
    Marco Volante
    Division of Pathology, Department of Clinical and Biological Sciences, University of Turin at San Luigi Hospital, Turin, Italy
    Histopathology 55:535-43. 2009
    ..The aim was to investigate the impact of individual pathological parameters in the diagnosis and prognosis of adrenocortical carcinoma...
  5. ncbi Emerging drugs for adrenocortical carcinoma
    Alfredo Berruti
    Department of Clinical and Biological Science, Oncologia Medica, University of Turin, Azienda Ospedaliera San Luigi, Regione Gonzole 10, 10043 Orbassano, Italy
    Expert Opin Emerg Drugs 13:497-509. 2008
    ..Adrenocortical carcinoma (ACC) is an extremely rare aggressive disease. Few data are available on the efficacy of systemic antineoplastic treatments (mitotane and cytotoxic therapy) in the treatment of advanced disease...
  6. ncbi Hyperhomocysteinemia in patients with Cushing's syndrome
    Massimo Terzolo
    Dipartimento di Scienze Cliniche e Biologiche, Medicina Interna I, Universita di Torino, 10100 Torino, Italy
    J Clin Endocrinol Metab 89:3745-51. 2004
    ..Hyperhomocysteinemia may be key to the prothrombotic state and increased cardiovascular risk of Cushing's syndrome...
  7. ncbi The neoplastic complications of acromegaly
    M Terzolo
    Department of Clinical and Biological Sciences, Internal Medicine I, A.S.O. San Luigi, University of Turin, Orbassano, Turin, Italy
    J Endocrinol Invest 26:32-4. 2003
  8. ncbi Colonoscopic screening and follow-up in patients with acromegaly: a multicenter study in Italy
    Massimo Terzolo
    Dipartimento de Scienze Cliniche e Biologische, Clinica Medica, Universita di Torino, Italy
    J Clin Endocrinol Metab 90:84-90. 2005
    ..Patients who are found to harbor a colonic neoplasia are at risk for recurrence...
  9. ncbi Subclinical Cushing's syndrome in adrenal incidentalomas
    Massimo Terzolo
    Division of Internal Medicine, University of Turin, Azienda Sanitaria Ospedaliera San Luigi, Regione Gonzole 10, 10043 Orbassano, Italy
    Endocrinol Metab Clin North Am 34:423-39, x. 2005
    ..The authors' aim is to present up-to-date information on the most relevant issues of subclinical Cushing's syndrome by addressing the many uncertainties and controversies surrounding this ill-defined endocrine condition...
  10. ncbi Midnight serum cortisol as a marker of increased cardiovascular risk in patients with a clinically inapparent adrenal adenoma
    Massimo Terzolo
    Dipartimento di Scienze Cliniche e Biologiche, Medicina Interna I, Universita di Torino, Turin, Orbassano, Italy
    Eur J Endocrinol 153:307-15. 2005
    ..In the present study, we have determined the prevalence of alterations of the hypothalamic-pituitary-adrenal axis in such patients and examined whether any correlation between endocrine data and the clinical phenotype exists...
  11. ncbi Subclinical Cushing's syndrome
    Massimo Terzolo
    Medicina Interna I, Dipartimento di Scienze Cliniche e Biologiche, Universita di Torino, ASO San Luigi, Orbassano, Italy
    Pituitary 7:217-23. 2004
    ....
  12. ncbi Management of adrenal incidentalomas
    M Terzolo
    Medicina Interna I, Dipartimento di Scienze Cliniche e Biologiche, , Orbassano, Italy
    Exp Clin Endocrinol Diabetes 115:166-70. 2007
  13. ncbi Ectopic ACTH syndrome: molecular bases and clinical heterogeneity
    M Terzolo
    Dipartimento di Scienze Cliniche e Biologiche, Medicina Interna I, Universita di Torino, Italy
    Ann Oncol 12:S83-7. 2001
    ..Conversely, SCLC processes POMC in an aberrant way releasing high concentrations of ACTH precursors and less intact ACTH in the circulation...
  14. ncbi The limited value of the desmopressin test in the diagnostic approach to Cushing's syndrome
    M Terzolo
    Dipartimento di Scienze Cliniche e Biologiche, Medicina Interna I, A S O San Luigi, Universita di Torino, Italy
    Clin Endocrinol (Oxf) 54:609-16. 2001
    ..The aim of the present study was to make a comparative evaluation of desmopressin and CRH tests in a consecutive cohort of patients with ACTH-dependent Cushing's syndrome and in a group of healthy subjects...
  15. ncbi Definition of an optimal strategy to evaluate and follow-up adrenal incidentalomas: time for further research
    Massimo Terzolo
    Medicina Interna I, Dipartimento di Scienze Cliniche e Biologiche, Facoltà di Medicina e Chirurgia San Luigi Gonzaga, Universita di Torino, ASO San Luigi Gonzaga, Regione Gonzole, 10, 10043 Orbassano, Torino, Italy
    Eur J Endocrinol 161:529-32. 2009
    ..To add further to the argument of discussion, we also outline a clinically-oriented strategy for follow-up. In conclusion, the need for further research appears evident to define more efficient guidelines...
  16. ncbi Adjunctive treatment of adrenocortical carcinoma
    Massimo Terzolo
    Department of Clinical and Biological Sciences, Internal Medicine, University of Turin, Turin, Italy
    Curr Opin Endocrinol Diabetes Obes 15:221-6. 2008
    ..Description of the adjunctive treatment strategies in patients with adrenocortical carcinoma after complete surgical resection...
  17. ncbi Subclinical Cushing's syndrome
    Massimo Terzolo
    Dipartimento di Scienze Cliniche e Biologiche, Medicina Interna I, A S O San Luigi, Universita di Torino, Italy
    Arq Bras Endocrinol Metabol 51:1272-9. 2007
    ..Either adrenalectomy or careful observation associated with treatment of the metabolic syndrome have been suggested as treatment options...
  18. ncbi Low-dose monitored mitotane treatment achieves the therapeutic range with manageable side effects in patients with adrenocortical cancer
    M Terzolo
    Dipartimento di Scienze Cliniche e Biologiche, Medicina Interna I, Universita di Torino, Italy
    J Clin Endocrinol Metab 85:2234-8. 2000
    ..The present data provide a rationale to change the approach to mitotane treatment in patients with adrenocortical carcinoma from high dose to low dose regimens...
  19. ncbi Management of adrenal incidentaloma
    Massimo Terzolo
    Medicina Interna I, Dipartimento di Scienze Cliniche e Biologiche, Universita di Torino, ASO San Luigi, Orbassano, Italy
    Best Pract Res Clin Endocrinol Metab 23:233-43. 2009
    ..Also the management of this condition is largely empirical, and data are insufficient to indicate the superiority of a surgical or non-surgical approach to managing patients with subclinical Cushing's syndrome...
  20. ncbi The patients with incidentally discovered adrenal adenoma (incidentaloma) are not at increased risk of osteoporosis
    G Osella
    Dipartimento di Scienze Cliniche e Biologiche, Medicina Interna I, A O San Luigi, 10043 Orbassano, Torino, Italy
    J Clin Endocrinol Metab 86:604-7. 2001
    ..The evaluation of BMD does not seem to be crucial in the management of incidentally discovered adrenal masses...
  21. ncbi Immunohistochemical assessment of Ki-67 in the differential diagnosis of adrenocortical tumors
    M Terzolo
    Dipartimento di Scienze Cliniche e Biologiche, Medicina Interna I, , Torino, Italy
    Urology 57:176-82. 2001
    ..High levels of Ki-67 seem to indicate patients with adrenocortical cancer with a worse prognosis...
  22. ncbi The value of dehydroepiandrosterone sulfate measurement in the differentiation between benign and malignant adrenal masses
    M Terzolo
    Dipartimento di Scienze Cliniche e Biologiche, Medicina Interna, Azienda Ospedaliera San Luigi, Universita di Torino, Italy
    Eur J Endocrinol 142:611-7. 2000
    ..Owing to their increasing rate of discovery as incidental findings, the characterization of adrenal masses is an important diagnostic problem which frequently challenges the clinician's skill...
  23. ncbi Favorable response of metastatic adrenocortical carcinoma to etoposide, adriamycin and cisplatin (EAP) chemotherapy. Report of two cases
    A Berruti
    Dipartimento di Scienze Cliniche e Biologische, , Italy
    Tumori 78:345-8. 1992
    ..Chemotherapy with the EAP regimen (6 courses) without interrupting mitotane attained a partial remission lasting 21+ months. We suggest that the EAP scheme is active in advanced ACC and that its association with mitotane is feasible...
  24. ncbi Long-term disease free survival in a patient with metastatic adreno-cortical carcinoma after complete pathological response to chemotherapy plus mitotane
    P Sperone
    Department of Clinical Oncology, University of Torino, San Luigi Hospital, Orbassano, Italy
    J Endocrinol Invest 29:560-2. 2006
    ..This report shows that chemotherapy plus mitotane could result in complete pathological remission, which may be a surrogate for long-term progression- free survival in metastatic ACC patients...
  25. ncbi Effects of high-intensity isokinetic exercise on salivary cortisol in athletes with different training schedules: relationships to serum cortisol and lactate
    P Paccotti
    Clinica Medica Generale, Dipartimento di Scienze Cliniche e Biologiche, Universita di Torino, Italy
    Int J Sports Med 26:747-55. 2005
    ..The interindividual differences in cortisol changes are likely to be related to the training status and mode as well as to the correspondence between the evaluation protocol and the discipline individually performed...
  26. ncbi Biochemical markers of bone and collagen turnover in acromegaly or Cushing's syndrome
    A Piovesan
    Dipartimento di Scienze Cliniche e Biologiche, , Turin, Italy
    Horm Metab Res 26:234-7. 1994
    ..Patients with CS were evaluated measuring serum and urinary cortisol (UFC), ACTH, BGP, PICP, PIIINP.(ABSTRACT TRUNCATED AT 250 WORDS)..
  27. ncbi Prevalence of adrenal incidentaloma in a contemporary computerized tomography series
    S Bovio
    Internal Medicine I, Department of Biological and Clinical Sciences, ASO San Luigi, University of Turin, Italy
    J Endocrinol Invest 29:298-302. 2006
    ..Notwithstanding that our subjects were at increased risk of lung cancer, the rate of adrenal metastases was low. We think that the present results can be generalized even if we may disclose the lack of histological diagnosis...
  28. ncbi Misdiagnosis of Cushing's syndrome in a patient receiving rifampicin therapy for tuberculosis
    M Terzolo
    Department of Clinical and Biological Sciences, S. Luigi Hospital, University of Torino, Italy
    Horm Metab Res 27:148-50. 1995
    ..The present case provides a practical example of the possibility to incorrectly suspecting Cushing's syndrome in patients treated with rifampicin, as previously envisaged by pharmacological studies...
  29. ncbi Pros and cons of dexamethasone suppression test for screening of subclinical Cushing's syndrome in patients with adrenal incidentalomas
    G Reimondo
    Internal Medicine I Endocrinology, Department of Clinical and Biological Sciences, A O U San Luigi Gonzaga, University of Turin, A S O San Luigi, Regione Gonzole 10, 10043 Orbassano, Italy
    J Endocrinol Invest 34:e1-5. 2011
    ..The 8-mg DST seems to replicate by large the results of the 1-mg DST...
  30. ncbi Bone loss is more severe in primary adrenal than in pituitary-dependent Cushing's syndrome
    M Minetto
    Dipartimento di Scienze Cliniche e Biologiche, Clinica Medica Generale, AO San Luigi, Regione Gonzole 10, 10043 Orbassano TO, Italia
    Osteoporos Int 15:855-61. 2004
    ..However, this hypothesis needs to be confirmed in large, prospective series of patients with Cushing's syndrome of different etiology...
  31. ncbi Adrenal pseudocyst mimicking cancer: a case report
    S Bovio
    Division of Internal Medicine I, Department of Biological and Clinical Science, A S O San Luigi, Orbassano, Italy
    J Endocrinol Invest 30:256-8. 2007
    ..We report herein the case of an adrenal hemorrhagic pseudocyst that simulated adrenocortical cancer and argue on the clinical clues for a differential diagnosis with other adrenal tumors...
  32. ncbi AME position statement on adrenal incidentaloma
    M Terzolo
    Medicine I, AOU San Luigi Gonzaga, University of Turin, Regione Gonzole 10, Orbassano 10043, Italy
    Eur J Endocrinol 164:851-70. 2011
    ..To assess currently available evidence on adrenal incidentaloma and provide recommendations for clinical practice...
  33. ncbi Interleukin-6 producing pheochromocytoma presenting with acute inflammatory syndrome
    M Minetto
    Department of Clinical and Biological Sciences, General Medical Clinic, San Luigi Hospital, Orbassano TO, Italy
    J Endocrinol Invest 26:453-7. 2003
    ..To our knowledge, our paper represents the 6th case report of IL-6 secreting pheochromocytoma associated with clinical markers of inflammatory response...
  34. ncbi Acromegaly due to ectopic secretion of GHRH by bronchial carcinoid in a patient with empty sella
    G Osella
    Department of Biological and Clinical Sciences, University of Turin, Turin, Italy
    J Endocrinol Invest 26:163-9. 2003
    ..Pituitary radiology showed an empty sella demonstrating for the first time its association with ectopic GHRH syndrome...
  35. ncbi Differential responses of serum and salivary interleukin-6 to acute strenuous exercise
    M Minetto
    Clinica Medica Generale, Dipartimento di Scienze Cliniche e Biologiche, , A.S.O. San Luigi, Regione Gonzole 10, 10043 Orbassano, Italy
    Eur J Appl Physiol 93:679-86. 2005
    ..Concomitant monitoring of serum markers of inflammation, muscle metabolism and damage can provide information about muscle function properties and adaptations to physical effort in different types of athletes...
  36. ncbi Adrenal incidentalomas and subclinical Cushing's syndrome: is there evidence for glucocorticoid-induced osteoporosis?
    A Angeli
    Dipartimento di Scienze Cliniche e Biologiche, , Cattedra di Medicina Interna I, Azienda Ospedaliera S. Luigi, Orbassano/TO, Italy
    Front Horm Res 30:73-85. 2002
  37. ncbi A rare case of adulthood-onset growth hormone deficiency presenting as sporadic, symptomatic hypoglycemia
    A Pia
    Division of Endocrinology and Metabolism, University of Turin, S. Luigi, Orbassano, Turin, Italy
    J Endocrinol Invest 27:1060-4. 2004
    ..The possible pathogenesis of isolated adult onset GHD and the association of GHD with conditions predisposing to hypoglycemia are considered and discussed...
  38. ncbi Prospective evaluation of mitotane toxicity in adrenocortical cancer patients treated adjuvantly
    Fulvia Daffara
    Medicina Interna I, A S O San Luigi, Regione Gonzole, 10, 10043 Orbassano, Italy
    Endocr Relat Cancer 15:1043-53. 2008
    ..A low-dose monitored regimen of mitotane is tolerable and able to maintain elevated drug concentrations in the long term. Mitotane exerts a complex effect on the endocrine system that may require multiple hormone replacement therapy...
  39. ncbi CYP11B2 -344T/C gene polymorphism and blood pressure in patients with acromegaly
    Paolo Mulatero
    Division of Internal Medicine, Hypertension Unit, Ospedale San Vito, Strada San Vito 34, 10133 Torino, Italy
    J Clin Endocrinol Metab 91:5008-12. 2006
    ..The pathogenesis of increased blood pressure (BP) in acromegaly is unclear, and the role of IGF-I levels and the renin-angiotensin-aldosterone system (RAAS) in this disease remains controversial...
  40. ncbi Etoposide, doxorubicin and cisplatin plus mitotane in the treatment of advanced adrenocortical carcinoma: a large prospective phase II trial
    Alfredo Berruti
    Oncologia Medica, , Azienda Ospedaliera San Luigi, Regione Gonzole 10 10043 Orbassano, Torino, Italy
    Endocr Relat Cancer 12:657-66. 2005
    ..Surgical resection of residual disease subsequent to chemotherapy leads to a more favourable outcome. The natural history of the disease is significantly influenced by the secretory status of the tumor...
  41. ncbi Prognostic significance of disordered calcium metabolism in hormone-refractory prostate cancer patients with metastatic bone disease
    M Tucci
    Dipartimento di Scienze Cliniche e Biologiche, Universita di Torino, Oncologia Medica, Azienda Ospedaliera San Luigi di Orbassano, Torino, Italy
    Prostate Cancer Prostatic Dis 12:94-9. 2009
    ..Patients with asymptomatic hypercalcemia could benefit of a strict follow-up and an immediate bisphosphonate treatment. Further prospective clinical trials are needed to confirm this finding...
  42. ncbi Increased osteoprotegerin levels in Cushing's syndrome are associated with an adverse cardiovascular risk profile
    Andrea Dovio
    Medicina Interna I, Dipartimento di Scienze Cliniche e Biologiche, Universita degli Studi di Torino, Reg Gonzole 10, 10043 Orbassano Torino, Italy
    J Clin Endocrinol Metab 92:1803-8. 2007
    ..Serum osteoprotegerin (OPG) levels are increased in patients with cardiovascular disease and/or excess bone resorption...
  43. ncbi Screening of Cushing's syndrome in adult patients with newly diagnosed diabetes mellitus
    Giuseppe Reimondo
    Dipartimento di Scienze Cliniche e Biologiche, Medicina Interna I, A S O San Luigi, Universita di Torino, Regione Gonzole 10, 10043 Orbassano, Italy
    Clin Endocrinol (Oxf) 67:225-9. 2007
    ..The threshold of adequate suppression after DST was set at 110 nmol/l...
  44. ncbi Gemcitabine plus metronomic 5-fluorouracil or capecitabine as a second-/third-line chemotherapy in advanced adrenocortical carcinoma: a multicenter phase II study
    Paola Sperone
    Dipartimento di Scienze Cliniche e Biologiche Università di Torino, Orbassano, Italy
    Endocr Relat Cancer 17:445-53. 2010
    ..3 (range: 1-43) and 9.8 months (range: 3-73) respectively. Gemcitabine plus metronomic fluoropyrimidines is a well-tolerated and moderately active regimen in heavily pretreated ACC patients...
  45. ncbi Subclinical Cushing's syndrome: definition and management
    M Terzolo
    Internal Medicine I, San Luigi Gonzaga Hospital, University of Turin, Orbassano, Italy
    Clin Endocrinol (Oxf) 76:12-8. 2012
    ..Most of the recommendations made in this chapter reflects the view and the clinical experience of the Authors and are not based on solid evidence...
  46. ncbi Matrix metalloproteinase type 2 expression in malignant adrenocortical tumors: Diagnostic and prognostic significance in a series of 50 adrenocortical carcinomas
    Marco Volante
    Division of Pathology, Department of Clinical and Biological Sciences, University of Turin and San Luigi Hospital, Orbassano, Torino, Italy
    Mod Pathol 19:1563-9. 2006
    ..In addition, a strong metalloproteinase type 2 expression in adrenocortical carcinoma was for the first time recognized as an unfavorable prognostic factor...
  47. ncbi Adrenocortical tumors with myxoid features: a distinct morphologic and phenotypical variant exhibiting malignant behavior
    Mauro Papotti
    Department of Clinical and Biological Sciences, University of Turin at St Luigi Hospital, Orbassano, Torino, Italy
    Am J Surg Pathol 34:973-83. 2010
    ....
  48. ncbi Evaluation of the effectiveness of midnight serum cortisol in the diagnostic procedures for Cushing's syndrome
    Giuseppe Reimondo
    Dipartimento di Scienze Cliniche e Biologiche, Medicina Interna I, A S O San Luigi, Universita di Torino, Orbassano 10043, Italy
    Eur J Endocrinol 153:803-9. 2005
    ..The aim of the present study was to assess retrospectively the effectiveness of F24 for confirming the diagnosis in a consecutive series of 106 patients, in 78 of whom a definitive diagnosis of CS was made...
  49. ncbi Secondary hypoadrenalism
    Giuseppe Reimondo
    Dipartimento di Scienze Cliniche e Biologiche, Medicina Interna I, Universita di Torino, ASO San Luigi, Orbassano 10043, Italy
    Pituitary 11:147-54. 2008
    ..Further studies with a systematic comparison of the different tests in large series of patients submitted to a prolonged follow-up are needed to solve the controversy of the optimal diagnostic strategy of SAI...
  50. ncbi The corticotrophin-releasing hormone test is the most reliable noninvasive method to differentiate pituitary from ectopic ACTH secretion in Cushing's syndrome
    Giuseppe Reimondo
    Dipartimento di Scienze Cliniche e Biologiche, Medicina Interna I, A S O San Luigi, Universita di Torino, Italy
    Clin Endocrinol (Oxf) 58:718-24. 2003
    ....
  51. ncbi A new simple HPLC method for measuring mitotane and its two principal metabolites Tests in animals and mitotane-treated patients
    Sivia De Francia
    Department of Clinical and Biological Sciences, Laboratory of Pharmacology, University of Turin, Ospedale San Luigi, Regione Gonzole 10, 10043 Orbassano TO, Italy
    J Chromatogr B Analyt Technol Biomed Life Sci 837:69-75. 2006
    ..Blood samples from mitotane-treated patients revealed two correlations: plasma mitotane/dichlrodiphenylethene and plasma mitotane/red cell mitotane...
  52. ncbi Laboratory differentiation of Cushing's syndrome
    Giuseppe Reimondo
    Dipartimento di Scienze Cliniche e Biologiche, Universita di Torino, Medicina Interna I, ASO San Lugi, Orbassano TO, Italy
    Clin Chim Acta 388:5-14. 2008
    ....
  53. ncbi The combined low-dose dexamethasone suppression corticotropin-releasing hormone test as a tool to rule out Cushing's syndrome
    Giuseppe Reimondo
    Dipartimento di Scienze Cliniche e Biologiche, Medicina Interna I, Universita di Torino, ASO San Luigi, Regione Gonzole, 10, 10043 Orbassano, Italy
    Eur J Endocrinol 159:569-76. 2008
    ..The aim of the present study was to evaluate whether the LDDST-CRH test may have a place in the diagnostic strategy of CS...
  54. ncbi Progression of renal failure without proteinuria in a patient with type 1 diabetes
    Giorgina Barbara Piccoli
    Department of Internal Medicine, University of Turin, Italy
    Nephrol Dial Transplant 19:3197-9. 2004
  55. ncbi Adrenal incidentaloma--a modern disease with old complications
    Alberto Angeli
    J Clin Endocrinol Metab 87:4869-71. 2002
  56. ncbi [Subclinical Cushing's syndrome in adrenal incidentalomas]
    Silvia Bovio
    Clinica Medica Generale, Azienda Ospedaliera San Luigi Gonzaga, Arbassano
    Recenti Prog Med 97:6-15. 2006
    ....
  57. ncbi Bone mineral density in acromegaly: the effect of gender, disease activity and gonadal status
    Alfredo Scillitani
    Division and Research Unit of Endocrinology, Ospedale Casa Sollievo della Sofferenza IRCCS, San Giovanni Rotondo FG, Italy
    Clin Endocrinol (Oxf) 58:725-31. 2003
    ..We have evaluated BMD in 152 acromegalic patients of both sexes with varying disease activity and gonadal status...
  58. ncbi Non-functioning pituitary adenoma database: a useful resource to improve the clinical management of pituitary tumors
    Emanuele Ferrante
    Endocrinology Unit, Department of Medical Sciences, University of Milan, Fondazione IRCCS Ospedale Maggiore, Policlinico, Mangiagalli e Regina Elena, Via F Sforza, 35, 20122 Milan, Italy
    Eur J Endocrinol 155:823-9. 2006
    ....
  59. ncbi Desmopressin test in mild Cushing syndrome
    Massimo Terzolo
    Arch Intern Med 163:850-1. 2003
  60. ncbi Myxoid adrenocortical adenoma with a pseudoglandular pattern
    Enrico R Bollito
    Division of Pathology, San Luigi Gonzaga Hospital, Reg. Gonzole, 10-10043 Orbassano, Italy
    Virchows Arch 445:414-8. 2004
    ....